Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1993-07-16
1995-11-28
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241841, 4241881, 4242041, 4242051, 4242071, 435 693, 4352351, 435236, 435237, 4352401, 4352402, 514 2, A61K 3921, C12N 700, C12N 510, C07K 14155
Patent
active
054705720
ABSTRACT:
A cell line capable of producing SIV viral materials without producing infectious viral particles is disclosed. The SIV viral particles produced are immunogenic and non-infectious. The cell line and the products produced by the cell line are useful for diagnostic purposes and for immunization purposes.
REFERENCES:
patent: 4752565 (1988-06-01), Folks et al.
Hernandez, S. et al. Symp. Nonhum. Primate Models AIDS abstract No. 87, (Nov. 1992).
Desrosiers, R. C. et al. Proc. Natl. Acad. Sci. USA 86: 6353-6357 (1989).
Marx, P. A. et al. J. Virol. 65(8): 4480-4485 (1991).
Norley, S. et al. Immunobiol. 184: 193-207 (1992).
Cohen, J. Science 262: 980-81 (1993).
E. Kraiselburd, et al., Characterization of Biologically Cloned CEMX174 Cells Expressing Non-Infectious SIV.sub.sm Particles IXth International Conference on AIDS, Berlin Abstract PO-A33-0798, Jun. 6-11, (1993).
P. R. Johnson et al. Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge Proc. Natl. Acad. Sci. USA, 89, 2175-2179 (1992).
J. A. Hoxie et al., Biological Characterization of a Simian Immunodeficiency Virus-Like Retrovirus (HTLV-IV): Evidence for CD4-Associated Molecules Required for Infection Journal of Virology 62, 2557-2568 (1988).
E. Kraiselburg et al.; Biochemical and Biological properties of SIV-chronically infected cells VIII International conference on AIDS, Amsterdam Jul. 19-24, 1992.
R. E. Benveniste et al.; Characterization of clones of HIV-1 Infected HuT 78 Cells Defective in gag Gene Processing and of SIV Clones Producing Large Amounts of Envelope Glycoprotein J. Med. Primatol, 19 pp. 351-366 (1990).
Hoxie, J. A. et al., "Persistent Noncytophatic Infection of Normal Human T-Lymphocytes with AIDS-Associated Retrovirus", Science 229:1400 (1985).
Folks, T. M. et al., "Induction of HTLV-III/LAV from a Nonvirus-Prodiucing T-Cell Line: Implications for Latency", Science 231:601 (1986).
Folks, T. M. et al., "Biological and Biochemical Characterization of a Cloned LEU-3 Cell Surviving Infection with the Acquired Immune Deficiency Syndrome Retrovirus", J. Exp. Med. 164240 (1986).
Folks, T. M. et al., "Characterization of Promonocyte Clone Chronically Infected with HIV and Inducible by 13-Phorbol-12-Myristate Acetate", J. Immunol. 140:1117 (1988).
Murphy-Corb, M. et al., "A Formalin-Inactivated Whole SIV Vaccine Confers Protection in Macaques", Science 246:1293 (1989).
Mosher Mary E.
Tuscan Michael S.
University of Puerto Rico
LandOfFree
Non-infectious simian immunodeficiency virus particles produced does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-infectious simian immunodeficiency virus particles produced , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-infectious simian immunodeficiency virus particles produced will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2011739